Dr. Rika N. Omalley, MD

Dr. Omalley practices at McLeod Health Loris in Loris, South Carolina, part of McLeod Health.

Dr. Omalley's NPI, 1003024365, was assigned on May 18, 2007. Dr. Omalley holds Pennsylvania license MD433881.

Dr. Omalley's primary practice is McLeod Health Loris, at 3655 Mitchell Street, Loris, SC 29569 in Horry County. The practice phone is (843) 716-7000.

Dr. Omalley's primary practice is McLeod Health Loris in Loris, South Carolina, part of McLeod Health. The medical group on file is ACS Primary Care Physicians - Southeast. Dmand AI also links Dr. Omalley to 3 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Omalley practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Omalley's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Omalley is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Omalley is licensed in Pennsylvania.

CMS data shows 424 Medicare services from Dr. Omalley across 4 procedure codes in 2024, for 427 Medicare patients. Medicare paid $47,684 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 427 Medicare patients who saw Dr. Omalley in 2024. The largest group is 75 to 84, with 184 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Omalley's median patient age at 58, with 57% women.

In 2024, Dr. Omalley wrote 221 Medicare Part D claims for 158 patients. 89% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $175 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

Dr. Omalley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Omalley to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 4 general payments to Dr. Omalley from 1 drug or device company from 2018 to 2025. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $1,620.